@article{ijcd2021911,
author={{Cornell, Hugh J. and Stelmasiak, Teodor and Lerner, Aaron},
title={Enzyme Therapy for Patients with Celiac Disease - An Update},
journal={International Journal of Celiac Disease},
volume={9},
number={1},
pages={28--34},
year={2021},
url={http://pubs.sciepub.com/ijcd/9/1/1},
issn={2334-3486},
abstract={Enzyme therapy as a management tool for patients with celiac disease (CD) or gluten intolerance is gaining acceptance around the world. Gluten has multiple side effects and limitations of a gluten-free diet (GFD) in management of CD are evident and mainly related to the presence of hidden gluten or cross-contamination of meals in restaurants. The present paper discusses enzyme therapy with caricain, namely Gluteguard, in light of various approaches searching for a treatment or an effective management of CD. Regular users of the supplement Gluteguard report a high level of satisfaction with the product. This indicates that enzyme therapy based on caricain has its place as a safeguard when the gluten-free meals are prepared outside the control of the patients.},
doi={10.12691/ijcd-9-1-1}
publisher={Science and Education Publishing}
}